Works matching DE "ACUTE myeloid leukemia"


Results: 5000
    1
    2
    3

    ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-61647-8
    By:
    • Jiang, Hua;
    • Fu, Denggang;
    • Pasupuleti, Santhosh Kumar;
    • Ramdas, Baskar;
    • Long, Alan;
    • Ramadan, Abdulraouf M.;
    • Yang, Jinfeng;
    • Kumar, Ramesh;
    • Hartman, Jessica H.;
    • Kendrick, B. Jacob;
    • Simpson, Ed;
    • Gao, Hongyu;
    • Liu, Yunlong;
    • Moore, Drew;
    • Subramanian, Suganya;
    • Berto, Stefano;
    • Gopalakrishnapillai, Anilkumar;
    • Barwe, Sonali P.;
    • Guo, Hongfen;
    • Cheung, Nai-Kong V.
    Publication type:
    Article
    4
    5
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    25
    26
    27
    28
    29

    L-2-hydroxyglutarate regulates centromere and heterochromatin conformation in the male germline.

    Published in:
    PLoS Genetics, 2025, v. 21, n. 7, p. 1, doi. 10.1371/journal.pgen.1011785
    By:
    • Mayorek, Nina;
    • Schlossberg, Miriam;
    • Mansour, Yousef;
    • Pillar, Nir;
    • Stein, Ilan;
    • Mushasha, Fatima;
    • Baziza Paz, Guy;
    • Medvedev, Eleonora;
    • Manevitch, Zakhariya;
    • Menzel, Julia;
    • Aizenshtein, Elina;
    • Sarvin, Boris;
    • Sarvin, Nikita;
    • Goldberg, Erwin;
    • Niedenberger, Bryan A.;
    • Geyer, Christopher B.;
    • Shlomi, Tomer;
    • Klutstein, Michael;
    • Pikarsky, Eli
    Publication type:
    Article
    30
    31
    32
    33
    34
    35

    ПОРІВНЯЛЬНА ХАРАКТЕРИСТИКА КІЛЬКІСНИХ ТА СТРУКТУРНИХ АНОМАЛІЙ ХРОМОСОМ НА ЧАС ВСТАНОВЛЕННЯ ДІАГНОЗУ ТА РЕЦИДИВАХ ГОСТРИХ МІЄЛОЇДНИХ ЛЕЙКЕМІЙ.

    Published in:
    Medical Perspectives / Medičnì Perspektivi, 2025, v. 30, n. 2, p. 140, doi. 10.26641/2307-0404.2025.2.333463
    By:
    • Андреєва, С. В.;
    • Корець, К. В.;
    • Скороход, І. М.;
    • Гартовська, І. Р.;
    • Мельник, У. І.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Unveiling New Triazoloquinoxaline‐Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9.

    Published in:
    Chemistry - A European Journal, 2025, v. 31, n. 34, p. 1, doi. 10.1002/chem.202404218
    By:
    • Pierri, Martina;
    • Bove, Guglielmo;
    • Gazzillo, Erica;
    • Colarusso, Ester;
    • Scala, Francesca;
    • Pepe, Giacomo;
    • Terracciano, Stefania;
    • Chini, Maria Giovanna;
    • Simonelli, Nicla;
    • Bruno, Ines;
    • Nebbioso, Angela;
    • Campiglia, Pietro;
    • Bifulco, Giuseppe;
    • Altucci, Lucia;
    • Del Gaudio, Nunzio;
    • Lauro, Gianluigi
    Publication type:
    Article
    45
    46
    47

    Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35960
    By:
    • Boyiadzis, Michael;
    • Wei, Andrew H.;
    • Paiva, Bruno;
    • Freeman, Sylvie D.;
    • Kaspers, Gertjan;
    • Chyla, Brenda;
    • Hersey, Sarah;
    • Patel, Reshma;
    • Maloney, Brian;
    • Blanchet Zumofen, Marie‐Helene;
    • Van Hoef, Marlies;
    • Wulff, Beate;
    • Obourn, Vanessa;
    • Patel, Shalaka;
    • Lopes de Menezes, Daniel;
    • Shi, Qian;
    • Bengoudifa, Bourras‐Rezki;
    • Dimier, Natalie;
    • Prior, Thomas J.;
    • Roboz, Gail J.
    Publication type:
    Article
    48
    49
    50